NCT01927640View on ClinicalTrials.gov

Dexmedetomidine for Reversal of Cocaine's Effects on the Heart

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

February 1, 2013

Primary Completion Date

January 15, 2014

Study Completion Date

January 15, 2014

Conditions

Chest PainAcute Coronary Syndrome

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine (0.3-0.6 mcg/kg) infusion.

DRUG

Normal Saline

Normal saline infusion (10 cc)

DRUG

Intranasal cocaine

Intranasal cocaine (2 mg/kg)

Trial Locations (1)

90048

Cedars-Sinai, Los Angeles

Sponsors

Collaborators (1)

Lincy Foundation

All Listed Sponsors

collaborator

Lincy Foundation

OTHER

lead

Cedars-Sinai Medical Center

OTHER